AVGR Insider Trading

Insider Ownership Percentage: 42.80%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $4,009.60

Avinger Insider Trading History Chart

This chart shows the insider buying and selling history at Avinger by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$4.01ksoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$4k-$2k$0$2k$4kTotal Insider BuyingTotal Insider Selling

Avinger Share Price & Price History

Current Price: $0.47
Price Change: +0.30 (1.20%)
As of 03/12/2025 01:00 AM ET

This chart shows the closing price history over time for AVGR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
AprMayJunJulAugSepOctNovDecJanFebMar$0.47Closing price on 03/13/25:

Avinger Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for Avinger (NASDAQ:AVGR)

18.30% of Avinger stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at AVGR by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
202220232024$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4-$1M-$500k$0$500k$1MTotal InflowsTotal Outflows
Avinger logo
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.
Read More on Avinger

Today's Range

Now: $0.47
Low: $0.47
High: $0.47

50 Day Range

MA: $0.55
Low: $0.39
High: $0.83

52 Week Range

Now: $0.47
Low: $0.36
High: $4.37

Volume

N/A

Average Volume

903,903 shs

Market Capitalization

$1.57 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.09

Who are the company insiders with the largest holdings of Avinger?

Avinger's top insider investors include:
  1. Jeffrey M Soinski (CEO)
  2. Himanshu Patel (CTO)
  3. Nabeel Paul Subainati (VP)
Learn More about top insider investors at Avinger.